A phase IIa study of Zimura (avacincaptad pegol) for intermediate/posterior non-infectious uveitis
Latest Information Update: 10 Jul 2019
At a glance
- Drugs Avacincaptad pegol (Primary)
- Indications Intermediate uveitis; Posterior uveitis
- Focus Therapeutic Use
- 31 Jul 2017 New trial record
- 26 Jul 2017 According to an OphthoTech Corporation media release, the company plans to initiate this study in 2018.